DocGo (NASDAQ:DCGO) Stock Rating Reaffirmed by Needham & Company LLC

DocGo (NASDAQ:DCGO – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Needham & Company LLC in a research note issued to investors on Thursday, Benzinga reports. They currently have a $7.00 price objective on the stock. Needham & Company LLC’s price target would indicate a potential upside of 97.74% from the […]

Leave a Reply

Your email address will not be published.

Previous post Capital Southwest (NASDAQ:CSWC) PT Lowered to $24.00 at B. Riley
Next post Cognizant Technology Solutions (NASDAQ:CTSH) Lifted to “Neutral” at Bank of America